Short notes from last concall:
- Ethylamine plant should be coming up by May or June 2023
- Above plant in four years down the line when full usage of our assets is being made could be between Rs. 600 to 800 crores on the top line
- Europe conflict increasing price of Amonia
- Should have a muted year in terms of sales growth. Managment pointed out domestic pharma is having slight slowdown which impacts sales.
- Overall for the company we may be between 70%-80% capacity utilization.’
- Top line decline is largely value driven, not volume driven. There’s been a drop in prices.
- At some stage perhaps we will get into making Dimethylformamide. (DMF)
Subscribe To Our Free Newsletter |